It is injected just under the skin by way of a pen injector. In 2014, Saxenda became the first GLP-1 agonist approved for weight loss in people without diabetes. It’s meant to be used along with ...

NICE tuned down the GLP-1 agonist earlier this year, but changed its stance after Novo Nordisk offered a confidential discount to the NHS. Saxenda – which comes as prefilled self-injection pen ...